{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:01Z","timestamp":1786119481665,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1097\/meg.0b013e32832b20d4","type":"journal-article","created":{"date-parts":[[2010,2,4]],"date-time":"2010-02-04T02:55:23Z","timestamp":1265252123000},"page":"334-339","source":"Crossref","is-referenced-by-count":13,"title":["Survey on the use of adalimumab as maintenance therapy in Crohn's disease in England and Ireland"],"prefix":"10.1097","volume":"22","author":[{"given":"Evangelos A.","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marietta","family":"Iacucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James O.","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailsa","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hamlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naila","family":"Arebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Nightingale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meron R.","family":"Jacyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M.","family":"Gabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian W.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"O'Morain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrata","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210207","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1053\/gast.2000.18160","article-title":"Tumour necrosis factor: biology and therapeutic inhibitors","volume":"119","author":"Papadakis","year":"2000","journal-title":"Gastroenterology"},{"key":"R2-11-20210207","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0140-6736(92)90999-J","article-title":"Tumour necrosis factor alpha in stool as a marker of intestinal inflammation","volume":"339","author":"Braegger","year":"1992","journal-title":"Lancet"},{"key":"R3-11-20210207","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1136\/gut.34.12.1705","article-title":"Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease","volume":"34","author":"Murch","year":"1993","journal-title":"Gut"},{"issue":"4","key":"R4-11-20210207","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2036.1999.00024.x","article-title":"Review article: targeting TNF alpha as a key cytokine in the inflammatory process of Crohn's disease \u2013 the mechanisms of action of infliximab","volume":"13","author":"Van Deventer","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"R5-11-20210207","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2005.11.030","article-title":"Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial","volume":"130","author":"Hanauer","year":"2006","journal-title":"Gastroenterology"},{"key":"R6-11-20210207","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-146-12-200706190-00159","article-title":"Adalimumab induction therapy for Crohn's disease previously treated with infliximab: a randomized trial","volume":"146","author":"Sandborn","year":"2007","journal-title":"Ann Intern Med"},{"key":"R7-11-20210207","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1136\/gut.2006.106781","article-title":"Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC-II trial","volume":"56","author":"Sandborn","year":"2007","journal-title":"Gut"},{"key":"R8-11-20210207","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","article-title":"Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial","volume":"132","author":"Colombel","year":"2007","journal-title":"Gastroenterology"},{"key":"R9-11-20210207","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"R10-11-20210207","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulising Crohn's disease","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med"},{"key":"R11-11-20210207","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2003.11.014","article-title":"Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease","volume":"126","author":"Rutgeerts","year":"2004","journal-title":"Gastroenterology"},{"key":"R12-11-20210207","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2036.2007.03583.x","article-title":"The use of adalimumab in the management of refractory Crohn's disease","volume":"27","author":"Ho","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R13-11-20210207","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1111\/j.1572-0241.2004.40462.x","article-title":"An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response to infliximab for Crohn's disease","volume":"99","author":"Sandborn","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R14-11-20210207","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1572-0241.2005.40647.x","article-title":"Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab","volume":"100","author":"Papadakis","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"R15-11-20210207","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2036.2006.03232.x","article-title":"Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial","volume":"25","author":"Hinojosa","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R16-11-20210207","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1365-2036.2007.03253.x","article-title":"Adalimumab in patients with Crohn's disease \u2013 safety and efficacy in an open-label single centre study","volume":"25","author":"Seiderer","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R17-11-20210207","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2036.2007.03254.x","article-title":"Adalimumab maintenance therapy for Crohn's disease with intolerance or lost response to infliximab: an open label study","volume":"25","author":"Peyrin-Biroulet","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R18-11-20210207","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1365-2036.2008.03828.x","article-title":"Immunogenicity negatively influences the outcome of adalimumab treatment in Crohn's disease","volume":"28","author":"West","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"R19-11-20210207","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2036.2008.03878.x","article-title":"Early clinical experience with adalimumab in treatment of inflammatory bowel disease in infliximab-treated and na\u00efve patients","volume":"29","author":"Swaminath","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"R20-11-20210207","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MPG.0b013e318174e886","article-title":"Safety and efficacy of adalimumab in pediatric patients with Crohn's disease","volume":"47","author":"Wyneski","year":"2008","journal-title":"J Paediatr Gastroenterol Nutr"},{"key":"R21-11-20210207","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/rheumatology\/kel326","article-title":"Dose escalation of the anti-TNF-\u03b1 agents in patients with rheumatoid arthritis. A systematic review","volume":"46","author":"Ariza-Ariza","year":"2007","journal-title":"Rheumatology"}],"container-title":["European Journal of Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042737-201003000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:15:47Z","timestamp":1786040147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042737-201003000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0b013e32832b20d4","relation":{},"ISSN":["0954-691X"],"issn-type":[{"value":"0954-691X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}